About HAII
HAII is a company based in Seoul (South Korea) founded in 2016 by Jinwoo Kim. HAII has raised $5.53 million across 1 funding round from investors including KB Securities, Dongwha Pharm and KB Investment. HAII offers products and services including Digital Biomarkers Platform and AI-Driven Solutions. HAII operates in a competitive market with competitors including Aiosyn, PaxeraHealth, Bio-AI Health, lifespin and Visla Labs, among others.
- Headquarter Seoul, South Korea
- Founders Jinwoo Kim
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$5.53 M (USD)
in 1 rounds
-
Latest Funding Round
$5.53 M (USD), Series B
Nov 23, 2022
-
Investors
KB Securities
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of HAII
HAII offers a comprehensive portfolio of products and services, including Digital Biomarkers Platform and AI-Driven Solutions.
AI tool for real-time health monitoring and diagnostics.
System for personalized therapeutics using large datasets.
Funding Insights of HAII
HAII has successfully raised a total of $5.53M through 1 strategic funding round. The most recent funding activity was a Series B round of $5.53 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $5.5M
-
First Round
First Round
(23 Nov 2022)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2022 | Amount | Series B - HAII | Valuation |
investors |
Investors in HAII
HAII has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include KB Securities, Dongwha Pharm and KB Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund investing in early-stage tech startups
|
Founded Year | Domain | Location | |
|
A venture capital firm focused on bio and healthcare investments.
|
Founded Year | Domain | Location | |
|
South Korean tech firms are invested in by Capstone Partners.
|
Founded Year | Domain | Location |
Investments & Acquisitions by HAII
Financial Statements - HAII
Haii Comparisons
Competitors of HAII
HAII operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aiosyn, PaxeraHealth, Bio-AI Health, lifespin and Visla Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-based tools are developed for clinical disease diagnosis by providers.
|
|
| domain | founded_year | HQ Location |
AI-based medical image management solutions are offered for organizations.
|
|
| domain | founded_year | HQ Location |
AI-based disease diagnosis is provided for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Cloud and AI-based diagnostics are provided for health providers.
|
|
| domain | founded_year | HQ Location |
Functions as an AI-based tool for disease diagnosis in healthcare.
|
|
| domain | founded_year | HQ Location |
AI-based tools are employed for disease diagnosis.
|
Latest news on Haii
Frequently Asked Questions about HAII
HAII was founded in 2016 and raised its 1st funding round 6 years after it was founded.
HAII is headquartered in Seoul, South Korea.
Jinwoo Kim is the current CEO of HAII. They have also founded this company.
HAII is a funded company, having raised a total of $5.53M across 1 funding round to date. The company's 1st funding round was a Series B of $5.53M, raised on Nov 23, 2022.
HAII was founded in 2016 in Seoul, South Korea, within the health technology sector. Digital biomarkers and diagnostic devices powered by AI are utilized to improve diagnosis and treatment of neurodegenerative diseases. Real-time monitoring of health conditions is enabled, along with support for personalized healthcare management. Operations are centered on integrating AI for enhanced medical insights in neurology.
HAII's top competitors include Aiosyn, Bio-AI Health and lifespin.
HAII offers Digital Biomarkers Platform and AI-Driven Solutions.
HAII has 6 investors. Key investors include KB Securities, Dongwha Pharm, KB Investment, Capstone Partners, and GeneN Investment Partners.